Trials / Completed
CompletedNCT03396120
The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes. Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Pulmonary function test | forced vital capacity and diffusing capacity |
Timeline
- Start date
- 2017-02-02
- Primary completion
- 2017-12-01
- Completion
- 2017-12-31
- First posted
- 2018-01-10
- Last updated
- 2018-01-10
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03396120. Inclusion in this directory is not an endorsement.